These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10950252)

  • 1. Trends in breast cancer incidence, survival, and mortality.
    Goodare H
    Lancet; 2000 Aug; 356(9229):591; author reply 593. PubMed ID: 10950252
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in breast cancer incidence, survival, and mortality.
    Benson JR; Purushotham A
    Lancet; 2000 Aug; 356(9229):591; author reply 593. PubMed ID: 10950251
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in breast cancer incidence, survival, and mortality.
    Pujol H
    Lancet; 2000 Aug; 356(9229):591-2; author reply 593. PubMed ID: 10950253
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in breast cancer incidence, survival, and mortality.
    Kaplan RM; Wingard DL
    Lancet; 2000 Aug; 356(9229):592-3. PubMed ID: 10950254
    [No Abstract]   [Full Text] [Related]  

  • 5. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    Farkas A; Ananth CV
    Obstet Gynecol; 2005 Jan; 105(1):218; author reply 218-9. PubMed ID: 15625172
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of tamoxifen treatment in patients with advanced breast cancer].
    Rolski J; Pawlicki M; Zemełka T; Pernal J
    Pol Merkur Lekarski; 1996 Oct; 1(4):271-3. PubMed ID: 9156943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 9. The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.
    Ryan PD; Goss PE
    Nat Clin Pract Oncol; 2005 Dec; 2(12):596-7. PubMed ID: 16341095
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in breast cancer incidence, survival, and mortality.
    Coleman MP
    Lancet; 2000 Aug; 356(9229):590-1; author reply 593. PubMed ID: 10950250
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current status and perspective in treatment of breast cancer in elderly women].
    Zhang BN; Zhang HM
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):161-4. PubMed ID: 18756927
    [No Abstract]   [Full Text] [Related]  

  • 12. [Utility of neoadjuvant endocrine therapy for breast neoplasms].
    Akashi-Tanaka S
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():559-62. PubMed ID: 17682211
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymph-node-negative oestrogen-receptor-positive breast cancer.
    Pansegrau GK; Gelmon KA
    Lancet; 2004 Sep 4-10; 364(9437):820-1. PubMed ID: 15351171
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of tamoxifen as treatment of breast cancer.
    Powles TJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-48-S1-54. PubMed ID: 9045315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the chance of relapse after tamoxifen treatment in breast cancer.
    Mihály Z; Szász AM; Győrffy B
    Biomark Med; 2014; 8(1):77-9. PubMed ID: 24325229
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicted trends in long-term breast cancer survival in England and Wales.
    Woods LM; Rachet B; Cooper N; Coleman MP
    Br J Cancer; 2007 Apr; 96(7):1135-8. PubMed ID: 17406350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
    Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
    J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
    [No Abstract]   [Full Text] [Related]  

  • 18. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 19. Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
    Van Poznak CH; Hayes DF
    J Natl Cancer Inst; 2006 Sep; 98(18):1261-3. PubMed ID: 16985239
    [No Abstract]   [Full Text] [Related]  

  • 20. A prognostic table to guide practitioners advising patients on adjuvant systemic therapy in early breast cancer.
    Stotter A
    Eur J Surg Oncol; 1999 Aug; 25(4):341-3. PubMed ID: 10419700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.